Next Article in Journal
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication
Next Article in Special Issue
Seroprevalence of SARS-CoV-2 Antibodies among Vaccinated and Non-Vaccinated Adults in the West Bank: Results of a Repeated Cross-Sectional Study
Previous Article in Journal
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
Previous Article in Special Issue
Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study
 
 
vaccines-logo
Article Menu

Article Menu

Article

Article Versions Notes

Vaccines 2022, 10(5), 717; https://doi.org/10.3390/vaccines10050717
Action Date Notes Link
article pdf uploaded. 4 May 2022 11:13 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/717/pdf-vor
article supplementary file uploaded. 4 May 2022 11:13 CEST - https://www.mdpi.com/2076-393X/10/5/717#supplementary
article xml file uploaded 11 May 2022 04:15 CEST Original file -
article xml uploaded. 11 May 2022 04:15 CEST Update https://www.mdpi.com/2076-393X/10/5/717/xml
article pdf uploaded. 11 May 2022 04:15 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/717/pdf
article html file updated 11 May 2022 04:17 CEST Original file -
article html file updated 2 August 2022 22:08 CEST Update https://www.mdpi.com/2076-393X/10/5/717/html
Back to TopTop